OPGN Share Price Performance
US$0.0001
-1.90 (-99.99%)
Price US$0.0001
Share PriceUS$0.0001
OpGen, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
OPGN Community Narratives
There are no narratives available yet.
Recent OPGN News & Updates
OpGen, Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.06
- Gross Margin
- 99.86%
- Net Profit Margin
- 212.01%
- Debt/Equity Ratio
- 0%
OpGen, Inc. Competitors
Snowflake Analysis
About OPGN
- Founded
- 2001
- Employees
- 1
- CEO
- WebsiteView website
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. OpGen, Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.S. Market Performance
- 7 Days: 1.2%
- 3 Months: 8.5%
- 1 Year: 17.7%
- Year to Date: 14.8%
The market is up 1.2% over the last week, with the Information Technology sector leading the way, up 2.4%. The market is up 18% over the last 12 months. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›